Koen Van Laere
Koen Van Laere is an expert in Nuclear medicine at Universitair Ziekenhuis Leuven (Belgium). As of October 2026, ScienceLeadR ranks Koen Van Laere in the top 1% of experts worldwide for Cognition Disorders, Basal Ganglia Diseases and Neurocognitive Disorders. Koen Van Laere has authored 622 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 10 of them ongoing. SLR score: 2,272 (community average: 125). How the SLR is computed.
LeadR Profile
Nuclear medicine
Subspecialties: Neurology - Psychiatry - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 622
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Multimodal Retinal Imaging for the Detection of Early Alzheimer's Disease: Combining Biochemical, Structural, and Vascular Biomarkers. PMID 42791913 — dementia, retina, alzheimer disease, pathology, cognitive dysfunction, biomarkers, machine learning, tomography, optical coherence, retinaldehyde | Bioengineering (Basel) | 2026 | 0 |
| PKiNN: a PET kinetics-informed neural network for dynamic PET kinetic modeling. PMID 42705322 — physics, biophysics, tissues | Phys Med Biol | 2026 | 0 |
| Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients. PMID 42332192 — neoplasms, positron emission tomography computed tomography, nuclear medicine, neuroendocrine tumors, wounds and injuries, octreotide | Eur J Nucl Med Mol Imaging | 2026 | 0 |
| 18F FDG-PET correlates of motor neuron disease motor variants. PMID 42262849 — sclerosis, neurons, motor neurons, positron-emission tomography, fluorodeoxyglucose f18, amyotrophic lateral sclerosis, motor neuron disease | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 0 |
| EXPRESS: Quantification of 18F-SynVesT-1 binding in healthy aging and head-to-head comparison with 11C-UCB-J. PMID 42219995 — aging, healthy volunteers, tissues, healthy aging | J Cereb Blood Flow Metab | 2026 | 0 |
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
10 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Prospective diagnostic performance of PET CT using the novel fibroblast imaging tracer 18F AlF FAPI 74 versus standard of care 18F FDG in inflammatory disorders 2024-516464-28-00 — fever of unknown origin, pain, immunoglobulin g4-related disease, positron emission tomography computed tomography, fluorodeoxyglucose f18, fibroblasts, therapeutics, back pain | Phase 2/Phase 3 | Recruiting | 2025 |
| Prospective head to head comparison of cardiac 18F MFBG PET versus 123I MIBG SPECT in the differentiation between Parkinson s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer s disease 2023-506508-18-00 — dementia, lewy bodies, atrophy, multiple system atrophy, parkinson disease, alzheimer disease, tomography, emission-computed, single-photon, 3-iodobenzylguanidine, head | Phase 2/Phase 3 | Recruiting | 2024 |
| A novel fibroblast imaging biomarker and ultrahigh resolution PET to improve the diagnosis and follow up of giant cell arteritis 2025-523880-39-02 — cells, arteries, arteritis, biomarkers, giant cells, diagnosis, fibroblasts, giant cell arteritis | Phase 2/Phase 3 | Recruiting | 2026 |
| Ultra High Resolution PET in Aging Neurodegeneration and Psychotic Disorders NCT07509125 — white matter, sclerosis, neurofibrillary tangles, locus coeruleus, dementia, lewy bodies, supranuclear palsy, progressive, spinal cord, atrophy, multiple system atrophy, frontotemporal dementia, parkinson disease, rem sleep behavior disorder, alzheimer disease, aging, sleep, brain, pathology, multiple chronic conditions, lewy body disease, cognitive dysfunction, positron emission tomography computed tomography, amyotrophic lateral sclerosis, schizophrenia, movement disorders, shy-drager syndrome, diagnosis, sleep, rem, healthy aging, paralysis, psychotic disorders, movement, spine | N/A | Recruiting | 2026 |
| Quantification of Hsp90 in the Human Brain NCT07380204 — sclerosis, parkinson disease, alzheimer disease, pharmaceutical preparations, aging, positron-emission tomography, brain, positron emission tomography computed tomography, amyotrophic lateral sclerosis, healthy aging, neurodegenerative diseases | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map